Anti-inflammatory drugs: What is safe?;Les anti-inflammatoires peuvent-ils être sans risque?

CMAJ. Canadian Medical Association Journal

Volumn 175, Issue 5, 2006, Pages

  Karsh, Jacob ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; CELECOXIB; CORTICOSTEROID DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR;

CARDIOVASCULAR RISK; CELL PROTECTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG SAFETY; EDITORIAL; FATALITY; HEART FAILURE; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; KIDNEY FAILURE; LONG TERM CARE; META ANALYSIS; OSTEOARTHRITIS; PAIN; PHYSICIAN; STOMACH HEMORRHAGE; STOMACH OBSTRUCTION; STOMACH PERFORATION; SYSTEMATIC REVIEW; CHRONIC DISEASE; PACKAGING; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; HUMANS; PAIN; PRODUCT LABELING; RISK ASSESSMENT;

EID: 33748350258     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060881     Document Type: Editorial

References (3)

1. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials. BMJ 2006;332:1302-8.
2. Gislason GH, Jacobsen S, Rasmussen JN, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase inhibitors and nonselective non-steroidal anti-inflammatory drugs after acute myocardial infarction. Circulation 2006;113:2906-13.
3. Hawker GA, Katz JN, Soloman DH. The patient's perspective on the recall of Vioxx. J Rheumatol 2006;33:1082-8.